Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -59.23% is 234% below its 5-year average of -17.71%, near the low end of its 5-year range (-82.99%–19.10%).
22.59% below its 12-month average of -48.32%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 17.76%.
OPERATING MARGIN
-59.23%
OPERATING MARGIN AVG TTM
-48.32%
OPERATING MARGIN AVG 3Y
-25.53%
OPERATING MARGIN AVG 5Y
-17.71%
OPERATING MARGIN AVG 10Y
-0.72%
OPERATING MARGIN AVG 15Y
-4.06%
OPERATING MARGIN AVG 20Y
-2.81%
CURRENT VS TTM AVG
-22.59%
CURRENT VS 3Y AVG
-131.99%
CURRENT VS 5Y AVG
-234.42%
CURRENT VS 10Y AVG
-8138.49%
CURRENT VS 15Y AVG
-1359.55%
CURRENT VS 20Y AVG
-2005.92%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
OraSure Technologies, Inc.
Market Cap
$259.56M
Operating Margin
-59.23%
TTM Avg
-48.32%
3Y Avg
-25.53%
5Y Avg
-17.71%
Market Cap
$259.49M
Operating Margin
-26.17%
TTM Avg
-26.03%
3Y Avg
-26.03%
5Y Avg
-20.02%
Market Cap
$259.14M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$259.12M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-2313.03%
5Y Avg
-2198.82%
Market Cap
$258.63M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-1307.00%
5Y Avg
-871.33%
Market Cap
$261.27M
Operating Margin
-247.44%
TTM Avg
-835.51%
3Y Avg
-417.75%
5Y Avg
-611.14%
Market Cap
$261.43M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-5599.55%
5Y Avg
-3879.66%
Market Cap
$256.47M
Operating Margin
-1927.32%
TTM Avg
-1059.56%
3Y Avg
-1070.46%
5Y Avg
-779.81%
Market Cap
$262.92M
Operating Margin
-59.68%
TTM Avg
-91.28%
3Y Avg
-192.69%
5Y Avg
-176.13%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OraSure Technologies, Inc. (OSUR) | $259.56M | -59.23% | -48.32% | -25.53% | -17.71% |
| Treace Medical Concepts, Inc. (TMCI)vs › | $259.49M | -26.17% | -26.03% | -26.03% | -20.02% |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $259.14M | 0.00% | 0.00% | 0.00% | 0.00% |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $259.12M | 0.00% | 0.00% | -2313.03% | -2198.82% |
| Palisade Bio, Inc. (PALI)vs › | $258.63M | 0.00% | 0.00% | -1307.00% | -871.33% |
| X4 Pharmaceuticals, Inc. (XFOR)vs › | $261.27M | -247.44% | -835.51% | -417.75% | -611.14% |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $261.43M | 0.00% | 0.00% | -5599.55% | -3879.66% |
| AC Immune S.A. (ACIU)vs › | $256.47M | -1927.32% | -1059.56% | -1070.46% | -779.81% |
| TriSalus Life Sciences, Inc. (TLSI)vs › | $262.92M | -59.68% | -91.28% | -192.69% | -176.13% |
| Anika Therapeutics, Inc. (ANIK)vs › | $255.88M | -4.24% | -7.03% | -2.53% | -5.01% |
Gross Margin
41.4%
Operating Margin
-59.2%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 17.76% |
| 2026-03-31 | -82.99% |
| 2025-12-31 | -62.97% |
| 2025-09-30 | -58.02% |
| 2025-06-30 | -55.35% |
| 2025-03-31 | -61.02% |
| 2024-12-31 | -30.90% |
| 2024-09-30 | -14.15% |
| 2024-06-30 | -0.06% |
| 2024-03-31 | -6.19% |
| 2023-12-31 | 10.20% |
| 2023-09-30 | 19.10% |
| 2023-06-30 | -7.31% |
| 2023-03-31 | 16.39% |
| 2022-12-31 | 11.76% |
| 2022-09-30 | 6.38% |
| 2022-06-30 | -13.62% |
| 2022-03-31 | -23.94% |
| 2021-12-31 | -14.68% |
| 2021-09-30 | -25.06% |
| 2021-06-30 | 2.74% |
| 2021-03-31 | 16.41% |
| 2020-12-31 | 10.18% |
| 2020-09-30 | 9.11% |
| 2020-06-30 | -34.39% |
| 2020-03-31 | -21.95% |
| 2019-12-31 | 10.10% |
| 2019-09-30 | 1.02% |
| 2019-06-30 | 14.25% |
| 2019-03-31 | -6.37% |
| 2018-12-31 | 26.84% |
| 2018-09-30 | 23.66% |
| 2018-06-30 | 17.76% |
| 2018-03-31 | 14.15% |
| 2017-12-31 | 19.53% |
| 2017-09-30 | 17.30% |
| 2017-06-30 | 17.14% |
| 2017-03-31 | 10.36% |
| 2016-12-31 | 19.92% |
| 2016-09-30 | 19.05% |
| 2016-06-30 | 13.87% |
| 2016-03-31 | 9.28% |
| 2015-12-31 | 12.64% |
| 2015-09-30 | 5.14% |
| 2015-06-30 | 8.95% |
| 2015-03-31 | -1.07% |
| 2014-12-31 | -8.94% |
| 2014-09-30 | 3.17% |
| 2014-06-30 | 9.46% |
| 2014-03-31 | -23.87% |
| 2013-12-31 | 21.08% |
| 2013-09-30 | -8.35% |
| 2013-06-30 | -22.91% |
| 2013-03-31 | -50.03% |
| 2012-12-31 | -27.77% |
| 2012-09-30 | -13.24% |
| 2012-06-30 | -15.65% |
| 2012-03-31 | -17.44% |
| 2011-12-31 | -1.18% |
| 2011-09-30 | -19.36% |
| 2011-06-30 | -12.37% |
| 2011-03-31 | -14.66% |
| 2010-12-31 | -4.95% |
| 2010-09-30 | 1.52% |
| 2010-06-30 | -2.78% |
| 2010-03-31 | -12.13% |
| 2009-12-31 | -16.29% |
| 2009-09-30 | 8.22% |
| 2009-06-30 | -30.71% |
| 2009-03-31 | -10.78% |
| 2008-12-31 | -35.86% |
| 2008-09-30 | -19.81% |
| 2008-06-30 | -20.10% |
| 2008-03-31 | -16.65% |
| 2007-12-31 | -7.28% |
| 2007-09-30 | -4.47% |
| 2007-06-30 | 2.74% |
| 2007-03-31 | 2.97% |
| 2006-12-31 | 4.48% |
| 2006-09-30 | 14.06% |
| 2006-06-30 | 7.42% |
| 2006-03-31 | 5.82% |
| 2005-12-31 | 12.10% |
| 2005-09-30 | 17.78% |
| 2005-06-30 | 5.52% |
| 2005-03-31 | 7.68% |
| 2004-12-31 | -3.52% |
| 2004-09-30 | -3.39% |
| 2004-06-30 | -0.38% |
| 2004-03-31 | -2.63% |
| 2003-12-31 | 3.19% |
| 2003-09-30 | 0.12% |
| 2003-06-30 | -5.73% |
| 2003-03-31 | -13.06% |
| 2002-12-31 | -1.49% |
| 2002-09-30 | -4.95% |
